Pain Management Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Pain Management Drugs Market was valued at approximately USD 65,108 million in 2020, and it is expected to witness a revenue of USD 86,505 million in 2027, with a CAGR of 4% over the forecast period 2021-2027.

Pain is an anxious sensory and emotional sensation caused by tissue damage or disease. Various disorders can also cause discomfort, such as multiple sclerosis, osteoarthritis, stomach ulcers, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer. Pain can range in length from short-term acute pain to long-term chronic pain. Acute pain can be mild and last only a short time or for a few weeks or months. Chronic pain is caused by aging bone and joint conditions, nerve damage or injury. A variety of drugs are used to manage pain caused by inflammation in response to tissue damage, chemicals/pathogens (nociceptive pain), or nerve damage (neuropathic pain). Most drugs affect biochemical processes in the body by binding to protein targets on cell membranes.


Market Segments

By Drug Class

  • NSAIDs
  • Anesthetics
  • Anticonvulsants
  • Anti-migraine Agents
  • Antidepressants
  • Opioids 
  • Nonnarcotic Analgesics 

By Indication

  • Arthritic Pain
  • Neuropathic Pain
  • Cancer Pain
  • Chronic Back Pain
  • Postoperative Pain
  • Migraine
  • Fibromyalgia
  • Muscle sprain/strain
  • Bone fracture 

Key Players

Some of the major companies operating in the global pain management drugs market are Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo Health Solutions, Inc., F. Hoffmann La Roche Ltd., Valeant Pharmaceuticals International Inc., Merck & Co. Inc., Allergen Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline Plc and Purdue Pharma L.P.


Scope of the Report

The research study analyzes the global Pain Management Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Pain Management Drugs Market Report

1. What was the Pain Management Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Pain Management Drugs Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Pain Management Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation